Thomas Eiwegger

9.2k total citations · 2 hit papers
98 papers, 3.5k citations indexed

About

Thomas Eiwegger is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Thomas Eiwegger has authored 98 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Immunology and Allergy, 44 papers in Physiology and 22 papers in Dermatology. Recurrent topics in Thomas Eiwegger's work include Allergic Rhinitis and Sensitization (51 papers), Food Allergy and Anaphylaxis Research (47 papers) and Asthma and respiratory diseases (44 papers). Thomas Eiwegger is often cited by papers focused on Allergic Rhinitis and Sensitization (51 papers), Food Allergy and Anaphylaxis Research (47 papers) and Asthma and respiratory diseases (44 papers). Thomas Eiwegger collaborates with scholars based in Austria, Canada and Switzerland. Thomas Eiwegger's co-authors include Cezmi A. Akdiş, Zsolt Szépfalusi, Liam O’Mahony, Eleonora Dehlink, Óscar Palomares, R. Urbanek, Heimo Breiteneder, David Holzmann, Norbert Meyer and Michael Soyka and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Scientific Reports.

In The Last Decade

Thomas Eiwegger

93 papers receiving 3.4k citations

Hit Papers

Interleukins, from 1 to 37, and interferon-γ: Receptors, ... 2011 2026 2016 2021 2011 2012 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Eiwegger Austria 29 1.5k 1.2k 801 639 467 98 3.5k
Óscar Palomares Spain 36 2.3k 1.6× 2.1k 1.8× 1.9k 2.4× 1.2k 1.8× 798 1.7× 117 5.6k
Zsolt Szépfalusi Austria 36 2.1k 1.4× 1.3k 1.1× 670 0.8× 957 1.5× 419 0.9× 148 4.1k
Emiko Noguchi Japan 33 859 0.6× 1.6k 1.4× 1.0k 1.3× 574 0.9× 728 1.6× 119 3.5k
Charles Pilette Belgium 38 1.2k 0.8× 2.1k 1.8× 1.1k 1.4× 450 0.7× 581 1.2× 143 4.5k
Stefan Zielen Germany 41 1.5k 1.0× 2.1k 1.8× 699 0.9× 592 0.9× 1.1k 2.3× 243 5.5k
Yuichi Kurono Japan 27 704 0.5× 741 0.6× 485 0.6× 216 0.3× 198 0.4× 184 2.8k
John W. Steinke United States 34 947 0.6× 1.9k 1.6× 1.5k 1.8× 243 0.4× 592 1.3× 105 4.5k
Lennart Greiff Sweden 33 1.7k 1.2× 2.3k 2.0× 701 0.9× 288 0.5× 330 0.7× 180 4.2k
Albrecht Bufe Germany 37 2.3k 1.6× 2.9k 2.5× 1.1k 1.4× 1.0k 1.6× 618 1.3× 102 5.2k
Els van Hoffen Netherlands 28 1.7k 1.2× 522 0.5× 751 0.9× 643 1.0× 461 1.0× 72 3.2k

Countries citing papers authored by Thomas Eiwegger

Since Specialization
Citations

This map shows the geographic impact of Thomas Eiwegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Eiwegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Eiwegger more than expected).

Fields of papers citing papers by Thomas Eiwegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Eiwegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Eiwegger. The network helps show where Thomas Eiwegger may publish in the future.

Co-authorship network of co-authors of Thomas Eiwegger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Eiwegger. A scholar is included among the top collaborators of Thomas Eiwegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Eiwegger. Thomas Eiwegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eiwegger, Thomas, et al.. (2024). From bite to brain: Neuro‐immune interactions in food allergy. Allergy. 79(12). 3326–3340. 5 indexed citations
2.
Çelik, Alper, Xiaojun Yin, Julia Upton, et al.. (2024). Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergy. Allergy. 80(1). 215–226. 5 indexed citations
3.
Eiwegger, Thomas, et al.. (2023). An alternative path to oral tolerance. Allergy. 78(7). 2058–2060. 1 indexed citations
5.
Upton, Julia, et al.. (2023). An update on recent developments and highlights in food allergy. Allergy. 78(9). 2344–2360. 14 indexed citations
6.
Jutel, Marek, Marı́a José Torres, Óscar Palomares, et al.. (2022). COVID‐19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations. Allergy. 77(8). 2313–2336. 14 indexed citations
7.
Çelik, Alper, Xiaojun Yin, Kai Yu, et al.. (2022). Precision cut intestinal slices, a novel model of acute food allergic reactions. Allergy. 78(2). 500–511. 6 indexed citations
8.
Mørtz, Charlotte G., George Du Toit, Kirsten Beyer, et al.. (2021). When and how to evaluate for immediate type food allergy in children with atopic dermatitis. Allergy. 76(12). 3845–3848. 6 indexed citations
9.
Agache, Ioana, Cezmi A. Akdiş, Mübeccel Akdiş, et al.. (2021). EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old. Allergy. 77(1). 17–38. 30 indexed citations
10.
Sokołowska, Milena, Thomas Eiwegger, Markus Ollert, et al.. (2021). EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines. Allergy. 76(6). 1629–1639. 83 indexed citations
11.
Breiteneder, Heimo, Yaqi Peng, Ioana Agache, et al.. (2020). Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy. 75(12). 3039–3068. 148 indexed citations
12.
Dai, Ruixue, Shahideh Safavi, Wendy Lou, et al.. (2020). Persistent ventilation inhomogeneity after an acute exacerbation in preschool children with recurrent wheezing. Pediatric Allergy and Immunology. 31(6). 608–615. 7 indexed citations
13.
Kothari, Akash, et al.. (2020). Emollients for the prevention of atopic dermatitis. Allergy. 76(8). 2641–2643. 2 indexed citations
14.
Agache, Ioana, Cezmi A. Akdiş, Mübeccel Akdiş, et al.. (2020). EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis. Allergy. 76(4). 988–1009. 25 indexed citations
16.
Breiteneder, Heimo, Zuzana Diamant, Thomas Eiwegger, et al.. (2019). Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy. 74(12). 2293–2311. 65 indexed citations
17.
Sewald, Katherina, et al.. (2019). Human ex vivo and in vitro disease models to study food allergy. Asia Pacific Allergy. 9(1). e4–e4. 11 indexed citations
18.
Kuessel, Lorenz, et al.. (2018). Local and systemic levels of cytokines and danger signals in endometriosis-affected women. Journal of Reproductive Immunology. 130. 7–10. 21 indexed citations
19.
Christiansen, Anders, Jens Vindahl Kringelum, Christian Hansen, et al.. (2015). High-throughput sequencing enhanced phage display enables the identification of patient-specific epitope motifs in serum. Scientific Reports. 5(1). 12913–12913. 62 indexed citations
20.
Szépfalusi, Zsolt, Saskia Gruber, Thomas Eiwegger, & Eleonora Dehlink. (2010). Clinical practice. European Journal of Pediatrics. 170(2). 137–148.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026